For the first time, we demonstrated that human SP-A genetic variants differentially attenuate ALI and affect survival rates post SARS-CoV-2 infection, by reducing viral burden, and differentially modulating viral-induced inflammatory responses. Here, SFTPA2 is linked to acute respiratory distress syndrome.